新兵中的耐多药结核病
Multidrug-resistant tuberculosis in military recruits.
作者信息
Freier Grace, Wright Allen, Nelson Gregory, Brenner Eric, Mase Sundari, Tasker Sybil, Matthews Karen L, Bohnker Bruce K
机构信息
Naval Hospital Beaufort-Branch Medical Clinic, Parris Island, South Carolina, USA.
出版信息
Emerg Infect Dis. 2006 May;12(5):760-2. doi: 10.3201/eid1205.050708.
Abstract
We conducted a tuberculosis contact investigation for a female military recruit with an unreported history of multidrug-resistant tuberculosis (MDRTB) and subsequent recurrence. Pertinent issues included identification of likely contacts from separate training phases, uncertainty on latent MDRTB infection treatment regimens and side effects, and subsequent dispersal of the contacts after exposure.
摘要
我们对一名有未报告的耐多药结核病（MDRTB）病史及后续复发情况的女性新兵进行了结核病接触者调查。相关问题包括确定来自不同训练阶段的可能接触者、潜伏性MDRTB感染治疗方案及副作用的不确定性，以及接触者在暴露后的后续分散情况。
相似文献
1
Multidrug-resistant tuberculosis in military recruits.新兵中的耐多药结核病
Emerg Infect Dis. 2006 May;12(5):760-2. doi: 10.3201/eid1205.050708.
2
Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.肺切除术联合基于异烟肼和利福平的药物治疗用于耐多药和广泛耐药结核病患者。
Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.
3
Do we have evidence for policy changes in the treatment of children with latent tuberculosis infection?我们是否有证据支持对潜伏性结核感染儿童的治疗政策进行改变？
Pediatrics. 2009 Mar;123(3):902-3. doi: 10.1542/peds.2008-2664.
4
[Reasons for drug-resistant tuberculosis emergence].[耐多药结核病出现的原因]
Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):403-5.
5
[Pulmonary tuberculosis caused by Mycobacterium bovis with primary resistance to Isoniazide and pyrazinamide].牛分枝杆菌引起的对异烟肼和吡嗪酰胺原发性耐药的肺结核
An Med Interna. 1997 Aug;14(8):433-4.
6
Drug-resistant tuberculosis among previously treated patients in Yangon, Myanmar.缅甸仰光接受过治疗的患者中的耐多药结核病
Int J Mycobacteriol. 2016 Sep;5(3):366-367. doi: 10.1016/j.ijmyco.2016.06.004. Epub 2016 Jun 23.
7
[The clinical features of tuberculosis in children and adolescents excreting drug-resistant Mycobacterium tuberculosis strains].[排出耐多药结核分枝杆菌菌株的儿童和青少年结核病的临床特征]
Probl Tuberk Bolezn Legk. 2009(6):13-6.
8
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.耐多药肺结核12个月治疗方案的结果
Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9.
9
Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.耐多药结核病患者成功治疗后的复发。
Int J Tuberc Lung Dis. 2011 Oct;15(10):1331-3. doi: 10.5588/ijtld.11.0098.
10
Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.采用异烟肼、利福平、乙胺丁醇和吡嗪酰胺治疗耐异烟肼结核病6个月。
Int J Tuberc Lung Dis. 2002 Nov;6(11):952-8.
引用本文的文献
1
Tuberculosis in Adolescents and Young Adults: Emerging Data on TB Transmission and Prevention among Vulnerable Young People.青少年和青年中的结核病：弱势青年人群中结核病传播与预防的新数据
Trop Med Infect Dis. 2021 Aug 5;6(3):148. doi: 10.3390/tropicalmed6030148.
2
Systematic Review, Meta-analysis, and Cost-effectiveness of Treatment of Latent Tuberculosis to Reduce Progression to Multidrug-Resistant Tuberculosis.为减少进展为耐多药结核病而进行潜伏性结核治疗的系统评价、荟萃分析及成本效益分析
Clin Infect Dis. 2017 Jun 15;64(12):1670-1677. doi: 10.1093/cid/cix208.
3
Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.2009 - 2012年密克罗尼西亚联邦耐多药结核病患者接触者的潜伏性结核感染治疗情况
Int J Tuberc Lung Dis. 2014 Aug;18(8):912-8. doi: 10.5588/ijtld.13.0028.
本文引用的文献
1
2
3
Update on the treatment of tuberculosis and latent tuberculosis infection.结核病及潜伏性结核感染治疗的最新进展
JAMA. 2005 Jun 8;293(22):2776-84. doi: 10.1001/jama.293.22.2776.
4
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.结核分枝杆菌DNA回旋酶：与喹诺酮类药物的相互作用及其与抗分枝杆菌药物活性的相关性。
Antimicrob Agents Chemother. 2004 Apr;48(4):1281-8. doi: 10.1128/AAC.48.4.1281-1288.2004.
5
Treatment of tuberculosis.结核病的治疗。
MMWR Recomm Rep. 2003 Jun 20;52(RR-11):1-77.
6
7
In vitro and in vivo activities of gatifloxacin against Mycobacterium tuberculosis.加替沙星对结核分枝杆菌的体外和体内活性
Antimicrob Agents Chemother. 2002 Apr;46(4):1022-5. doi: 10.1128/AAC.46.4.1022-1025.2002.
8
Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society.潜伏性结核感染的靶向结核菌素检测与治疗。美国胸科学会。
MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51.
9
Diagnostic Standards and Classification of Tuberculosis in Adults and Children. This official statement of the American Thoracic Society and the Centers for Disease Control and Prevention was adopted by the ATS Board of Directors, July 1999. This statement was endorsed by the Council of the Infectious Disease Society of America, September 1999.《成人及儿童结核病诊断标准与分类》。本美国胸科学会和疾病控制与预防中心的官方声明于1999年7月由美国胸科学会董事会通过。本声明于1999年9月得到美国传染病学会理事会的认可。
Am J Respir Crit Care Med. 2000 Apr;161(4 Pt 1):1376-95. doi: 10.1164/ajrccm.161.4.16141.
10
Asymptomatic hepatitis in persons who received alternative preventive therapy with pyrazinamide and ofloxacin.接受吡嗪酰胺和氧氟沙星替代预防治疗的人群中的无症状性肝炎。
Clin Infect Dis. 1997 Jun;24(6):1264-5. doi: 10.1093/clinids/24.6.1264.
Zotero 插件